Predictive value of a severity-of-illness score for toxic epidermal necrolysis (SCORTEN) factors for in-hospital mortality in Stevens–Johnson syndrome/toxic epidermal necrolysis
These findings support continued use of SCORTEN while highlighting the need to recalibrate or augment its parameters-particularly renal and oncologic variables-to improve risk stratification in current therapeutic contexts.
Authors
- Yuri V. Streltsov
- Ekaterina A. Nikitina (ORCID: https://orcid.org/0000-0002-0865-8355)
- D. S. Fomina
- Marina S Lebedkina
- Alexander Fedorovsky
- Tatiana Kruglova
- Maryana Lysenko
- Alexander Dushkin
- Alexander Karaulov
- Sergey Andreev
- Ulyana Markina
Institutions
- Sechenov University (RU)
- Lomonosov Moscow State University (RU)
- Presidential Executive Office (RU)
- Pirogov Russian National Research Medical University (RU)
- Moscow Clinical Scientific Center (RU)
- Clinical Hospital No. 8 (RU)
- Moscow Research and Clinical Center for Neuropsychiatry (RU)
- Astana Medical University (KZ)
- Moscow State University (TJ)
- Research Center of Neurology (RU)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-01-12
- DOI
- https://doi.org/10.3389/fmed.2025.1735242
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00